{Reference Type}: Journal Article
{Title}: Echocardiographic Manifestations in COVID-19: A Review.
{Author}: Carrizales-Sepúlveda EF;Vera-Pineda R;Flores-Ramírez R;Hernández-Guajardo DA;Pérez-Contreras E;Lozano-Ibarra MM;Ordaz-Farías A;
{Journal}: Heart Lung Circ
{Volume}: 30
{Issue}: 8
{Year}: Aug 2021
{Factor}: 2.838
{DOI}: 10.1016/j.hlc.2021.02.004
{Abstract}: COVID-19 has rapidly spread around the world and threatened global health. Although this disease mainly affects the respiratory system, there is increasing evidence that SARS-CoV-2 also has effects on the cardiovascular system. Echocardiography is a valuable tool in the assessment of cardiovascular disease. It is cost-effective, widely available and provides information that can influence management. Given the risk of personnel infection and equipment contamination during echocardiography, leading world societies have recommended performing echocardiography only when a clinical benefit is likely, favouring focussed evaluations and using smaller portable equipment. In the past months, multiple reports have described a wide pattern of echocardiographic abnormalities in patients with COVID-19. This review summarises these findings and discusses the possible mechanisms involved.